<https://rdf.molmedb.upol.cz/reference/ref2797> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane23>,
		<https://identifiers.org/molmedb/MM00585>;
	<http://purl.org/ontology/bibo/pmid> "23514631"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.ejmech.2013.02.007"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM474767>;
	<http://purl.org/dc/terms/bibliographicCitation> "Ramanujulu PM, Yang T, Yap SQ, Wong FC, Casey PJ, Wang M, Go ML.: Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt). Eur J Med Chem, Volume 63, 2013"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane38> .
<https://rdf.molmedb.upol.cz/interaction/int983599> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2797> .
<https://rdf.molmedb.upol.cz/interaction/int983621> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2797> .